Last reviewed · How we verify

NCT02073175

Development of Dietary Supplements for Mood Symptoms in Postpartum

Completed Phase 2 Last updated 11 April 2016
What this trial tests

Phase 2 trial testing Motherwell in Postpartum Blues in 28 participants. Completed in 1 April 2016.

Timeline
1 February 2014
Primary endpoint
1 April 2016
1 April 2016

Quick facts

Lead sponsorCentre for Addiction and Mental Health
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment28
Start date1 February 2014
Primary completion1 April 2016
Estimated completion1 April 2016
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Centre for Addiction and Mental Health — full company profile →

Who can join

Adults 18 to 45, female only, with Postpartum Blues or Healthy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood.
    Dowlati Y, Ravindran AV, Segal ZV, Stewart DE, et al · · 2017 · cited 24× · PMID 28289215 · DOI 10.1073/pnas.1611965114

Verify or expand the search:

Other trials of Motherwell

Trials testing the same drug.

Other Centre for Addiction and Mental Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02073175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing